On Tuesday, Alto Neuroscience Inc. (NYSE: ANRO) was 1.68% up from the session before settling in for the closing price of $14.29. A 52-week range for ANRO has been $7.91 – $24.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -50.00% over the past five years. When this article was written, the company’s average yearly earnings per share was at 72.85%. With a float of $22.18 million, this company’s outstanding shares have now reached $26.88 million.
Let’s look at the performance matrix of the company that is accounted for 63 employees. In terms of profitability, gross margin is 22.31%, operating margin of -14572.58%, and the pretax margin is -13388.44%.
Alto Neuroscience Inc. (ANRO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Alto Neuroscience Inc. stocks. The insider ownership of Alto Neuroscience Inc. is 17.74%, while institutional ownership is 68.21%. The most recent insider transaction that took place on Jul 09 ’24, was worth 152,085. In this transaction CHIEF MEDICAL OFFICER of this company bought 12,069 shares at a rate of $12.60, taking the stock ownership to the 36,920 shares. Before that another transaction happened on Jul 10 ’24, when Company’s CHIEF MEDICAL OFFICER bought 2,931 for $13.22, making the entire transaction worth $38,748. This insider now owns 39,851 shares in total.
Alto Neuroscience Inc. (ANRO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -7.77 earnings per share (EPS) during the time that was less than consensus figure (set at -1.67) by -6.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.85% per share during the next fiscal year.
Alto Neuroscience Inc. (NYSE: ANRO) Trading Performance Indicators
You can see what Alto Neuroscience Inc. (ANRO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.85.
Technical Analysis of Alto Neuroscience Inc. (ANRO)
Alto Neuroscience Inc. (NYSE: ANRO) saw its 5-day average volume 0.71 million, a positive change from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 84.54%. Additionally, its Average True Range was 0.83.
During the past 100 days, Alto Neuroscience Inc.’s (ANRO) raw stochastic average was set at 68.67%, which indicates a significant decrease from 90.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.09% in the past 14 days, which was lower than the 83.70% volatility it showed in the past 100 days.
Nevertheless, the first resistance level for the watch stands at $14.77 in the near term. At $15.01, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.32. If the price goes on to break the first support level at $14.22, it is likely to go to the next support level at $13.91. The third support level lies at $13.67 if the price breaches the second support level.
Alto Neuroscience Inc. (NYSE: ANRO) Key Stats
There are 26,884K outstanding shares of the company, which has a market capitalization of 391.73 million. As of now, sales total 0 K while income totals -36,310 K. Its latest quarter income was 0 K while its last quarter net income were -16,030 K.
